PCSK9 and familial hypercholesterolemia: We estimated that in more than 80% of those with a clinical diagnosis of autosomal dominant FH but with no detectable mutation in LDLR/APOB/PCSK9, the polygenic explanation is most likely cause of their hypercholesterolemia [10].